View Clinical Trial (Medical Research Study)


Population Pharmacokinetic Analysis of Anidulafungin in Normal, Overweight and Obese Volunteers

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Signup
Browse Studies

City:   Dallas
State:   Texas
Zip Code:   75390
Conditions:   Obesity - Mycoses
Purpose:   This study will find how weight affects the dosing of a drug called anidulafungin. Currently, the amount of anidulafungin a patient receives is the same regardless of the patient's weight.
Study Summary:  
Criteria:   Inclusion Criteria: - Male and female subjects, age > 18 years old, of all racial and ethnic origins. - Non-English-speaking Spanish speakers will be included in the study. - The investigators are recruiting six normal or underweight (BMI < 25 kg/m2), six overweight or obese (BMI 25-40 kg/m2), and six extremely obese (BMI > 40 kg/m2) for this study. This index is calculated using the volunteer's height and weight (Formula: weight (lb) / [height (in)]2 x 703). Half of each group will be male; the other half will be female. Exclusion Criteria: - Pregnant or nursing or unwilling to use a reliable contraception method during the study. The effects of anidulafungin on pregnancy are unknown. In addition, the metabolic changes that accompany pregnancy may alter the concentration-time profile of anidulafungin, so that the pregnancy and postpartum state would be a confounding variable. - Abnormal liver function tests: transaminases > 3 times upper limit of normal, Alkaline phosphatase > 3 times upper limit of normal, total bilirubin > 3 times upper limit of normal. - History of allergies to echinocandins. - Echinocandins are contraindicated for any reason. - Volunteers unwilling to comply with study procedures. - Suspected or documented systemic fungal infection. - Concomitant use of rifamycins, tacrolimus, or cyclosporine. - Current participation or previous participation within 28 days of enrollment in another research study that involves the use of medication, contrast, or any other compound that may alter blood count and/or blood chemistry (liver function, kidney function or electrolyte balance) (Unless waved by PI). - Donation of 450mL (one unit) of blood or more within 8 weeks (56 days) prior to study enrollment (Unless waved by PI). - Creatinine Clearance < 70 ml/min as estimated by the Cockcroft-Gault equation.
NCT ID:   NCT01307930
Primary Contact:   Principal Investigator
Ronald Hall, PharmD, MSCS
Texas Tech UHSC

Backup Contact:   N/A
Location Contact:   Dallas, Texas 75390
United States



There is no listed contact information for this specific location.

Site Status: N/A

Data Source:   ClinicalTrials.gov
Date Processed:   July 28, 2014
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

    (updated 55 minutes ago)
Within 25 Miles

Asthma - Plano TX

Multiple Sclerosis - Plano TX

Osteoarthritis of the hip - Dallas TX

Systemic Lupus Erythematosus - Dallas TX

Rheumatoid Arthritis - Dallas TX

Breathing Problems - Dallas TX

Rheumatoid Arthritis (TNF failure) - Dallas TX

Breathing Problems - Dallas TX

Type 2 Diabetes Mellitus - Plano TX

Rheumatoid Arthritis - Carrollton TX

Rheumatoid Arthritis - Mesquite TX

Adolescent Major Depression (Ages 12-17) - Plano TX

Major Depression - Dallas TX

Type 2 Diabetes - Dallas TX

Opioid Induced Constipation - Dallas TX

High Cholesterol - Dallas TX

Constipation - Dallas TX

Adolescent Major Depression (Ages 12-17) - Dallas TX

Bipolar Disorder - Dallas TX

Diabetic Foot Sores - Dallas TX

Diabetic Foot Sores - Dallas TX

Asthma - Mckinney TX

Diabetes and COPD or Asthma - Dallas TX

Smoking Cessation (Teens Ages 12 - Desoto TX

Asthma - Dallas TX2

Type 2 Diabetes - Dallas TX

Smoking Cessation (Teens Ages 12 - Dallas TX

Asthma - Allen TX

Asthma - Dallas TX

Rheumatoid Arthritis - Dallas TX

Rheumatoid Arthritis (DMARD Treatment Failure) - Dallas TX

Rheumatoid Arthritis (Treatment Failure) - Dallas TX

Rheumatoid Arthritis - Dallas TX

Endometriosis - Dallas TX

Type 2 Diabetes - Dallas TX

Asthma - Mckinney TX

Asthma - Dallas TX

Endometriosis - Dallas TX

Migraine Headaches - Arlington TX

Diabetic Neuropathy - Dallas TX

Osteoarthritis of the Knee - Arlington TX

Type 2 Diabetes - Arlington TX

Schizophrenia - Dallas TX

Endometriosis - Dallas TX

Type 2 Diabetes - Dallas TX

Chronic Constipation - Plano TX

Type 2 Diabetes - Plano TX

Rheumatoid Arthritis - Dallas TX

Asthma - Dallas TX

Healthy Volunteers (Hepatitis B Vaccine) - Dallas TX

Healthy Volunteers (Hepatitis B Vaccine) - Plano TX

Constipation - Dallas TX

Healthy Volunteers - Plano TX

Asthma - Dallas TX

Type 2 Diabetes - Dallas TX

Type 2 Diabetes - Dallas TX

Type 2 Diabetes - Mckinney TX

Asthma - Allen TX

Athlete’s Foot - Plano TX

Facial Acne - Dallas TX

High Cholesterol - Dallas TX

High Cholesterol - Dallas TX

High Cholesterol - Arlington TX

Within 50 Miles

Diabetic Foot Sores - Fort Worth TX

Asthma - Arlington TX

Asthma - Arlington TX

Asthma - Arlington TX

Type 2 Diabetes - North Richland Hills TX

High Cholesterol - Hurst TX

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - Arlington TX

Within 100 Miles

Diabetic Foot Sores - Weatherford TX